Concepedia

Kenta Yokoi

KY

Statistics

Publications

12

Citations

286

H-Index

12

Active since

2017

Affiliations

Tokyo University of Science(Current)

Japan Science and Technology Agency

Nagoya University

Kenta Yokoi is an author at Tokyo University of Science specializing in oncology, apoptosis, and molecular oncology.

ORCID

Publications per year

2017–2024

12

Publications

12

Survival pathway of cholangiocarcinoma via AKT/mTOR signaling to escape RAF/MEK/ERK pathway inhibition by sorafenib

Kenta Yokoi, Akira Kobayashi, Hiroaki Motoyama et al. · Oncology Reports · 2017 · 39 citations · Full text

, , +17

Synthesis and Anticancer Properties of Bis‐ and Mono(cationic peptide) Hybrids of Cyclometalated Iridium(III) Complexes: Effect of the Number of Peptide Units on Anticancer Activity

Jebiti Haribabu, Yuichi Tamura, Kenta Yokoi et al. · European Journal of Inorganic Chemistry · 2021 · 33 citations

, , +13

Cyclometalated Iridium(III) Complex–Cationic Peptide Hybrids Trigger Paraptosis in Cancer Cells via an Intracellular Ca2+ Overload from the Endoplasmic Reticulum and a Decrease in Mitochondrial Membrane Potential

Chandrasekar Balachandran, Kenta Yokoi, K Naito et al. · Molecules · 2021 · 28 citations · Full text

, , +16

Amphiphilic Cationic Triscyclometalated Iridium(III) Complex–Peptide Hybrids Induce Paraptosis-like Cell Death of Cancer Cells via an Intracellular Ca<sup>2+</sup>-Dependent Pathway

Kenta Yokoi, Chandrasekar Balachandran, Masakazu Umezawa et al. · ACS Omega · 2020 · 27 citations · Full text

, , +16

Induction of Paraptosis by Cyclometalated Iridium Complex-Peptide Hybrids and CGP37157 via a Mitochondrial Ca<sup>2+</sup>Overload Triggered by Membrane Fusion between Mitochondria and the Endoplasmic Reticulum

Kenta Yokoi, Kohei Yamaguchi, Masakazu Umezawa et al. · Biochemistry · 2022 · 27 citations · Full text

, , +17

1–5 of 12